Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2401 of 3330
Next
>>
>
60001 to 60025 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0107	uM	10817.155	0.9705	0.9630	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0107	uM	10817.155	0.9705	0.9630	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0533	uM	10817.155	0.8949	0.8663	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0533	uM	10817.155	0.8949	0.8663	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.267	uM	10817.155	0.8142	0.7595	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.267	uM	10817.155	0.8142	0.7595	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	1.33	uM	10817.155	0.8404	0.7945	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	1.33	uM	10817.155	0.8404	0.7945	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	6.67	uM	10817.155	0.7597	0.6852	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	6.67	uM	10817.155	0.7597	0.6852	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	33.3	uM	10817.155	0.3946	0.1203	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	33.3	uM	10817.155	0.3946	0.1203	1.6045
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0000853	uM	12365.155	0.9765	0.9776	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0000853	uM	12365.155	0.9765	0.9776	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.000427	uM	12365.155	0.9457	0.9478	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.000427	uM	12365.155	0.9457	0.9478	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.00213	uM	12365.155	1.0322	1.0302	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.00213	uM	12365.155	1.0322	1.0302	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0107	uM	12365.155	0.9959	0.9961	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0107	uM	12365.155	0.9959	0.9961	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0533	uM	12365.155	0.9068	0.9094	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.0533	uM	12365.155	0.9068	0.9094	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.267	uM	12365.155	0.8775	0.8799	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	0.267	uM	12365.155	0.8775	0.8799	2.1113
MCF12A	NM	Basal B	PD184352	MEK	MAPK	1.33	uM	12365.155	0.8323	0.8334	2.1113

|<
<<
Previous
Page 2401 of 3330
Next
>>
>
60001 to 60025 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)